Strategic Intelligence for Hedge Funds & Private Equity
De-risk Investments. Validate Assets. Navigate Clinical Landscape.
At EHG, we provide institutional investors with deep, operationally grounded insights into the clinical research ecosystem. Our team combines decades of experience in clinical trial conduct, patient recruitment, and regulatory compliance to support investment decisions with high-fidelity, real-world intelligence. Whether you’re evaluating a diagnostics company, a biotech asset, or a clinical trial management technology, our insights go beyond pitch decks and press releases—we offer the reality from inside the research process.
Evidence-Based Investment Support
Clinical Asset Diligence
Independent assessments of investigational product feasibility, protocol design risks, and trial execution complexity
Site & Investigator Network Analysis
Evaluation of recruitment footprint, geographic scalability, and operational viability of trial networks
Patient Access Modeling
Real-world estimates of patient identification, engagement, and retention, particularly for rare or high-risk populations
Trial Timeline & Risk Forecasting
Historical and predictive analysis of study activation, enrollment, and completion across therapeutic areas
Clinical Infrastructure Readiness
Review of biospecimen handling, data capture processes, and compliance risk across study partners
Competitive Intelligence
Real-world benchmarking of trial design, site activation, patient engagement, and cost drivers
Real-World Knowledge. Real Returns.
Why EHG
Led by a registered nurse and clinical operations expert with over 25 years of front line experience, we deliver intelligence grounded in execution, not theory. Our input helps investors understand not just what is being studied—but how likely it is to succeed.
Let's Discuss Your Next Deal
We support diligence timelines from rapid 48-hour assessments to full portfolio monitoring. Contact us to schedule a confidential consultation.